investors.atarabio.com investors.atarabio.com

investors.atarabio.com

Investor Relations - Atara Biotherapeutics

The Investor Relations website contains information about Atara Biotherapeutics business for stockholders, potential investors, and financial analysts.

http://investors.atarabio.com/

WEBSITE DETAILS
SEO
PAGES
SIMILAR SITES

TRAFFIC RANK FOR INVESTORS.ATARABIO.COM

TODAY'S RATING

>1,000,000

TRAFFIC RANK - AVERAGE PER MONTH

BEST MONTH

January

AVERAGE PER DAY Of THE WEEK

HIGHEST TRAFFIC ON

Sunday

TRAFFIC BY CITY

CUSTOMER REVIEWS

Average Rating: 4.4 out of 5 with 10 reviews
5 star
7
4 star
2
3 star
0
2 star
0
1 star
1

Hey there! Start your review of investors.atarabio.com

AVERAGE USER RATING

Write a Review

WEBSITE PREVIEW

Desktop Preview Tablet Preview Mobile Preview

LOAD TIME

0.5 seconds

FAVICON PREVIEW

  • investors.atarabio.com

    16x16

  • investors.atarabio.com

    32x32

CONTACTS AT INVESTORS.ATARABIO.COM

Login

TO VIEW CONTACTS

Remove Contacts

FOR PRIVACY ISSUES

CONTENT

SCORE

6.2

PAGE TITLE
Investor Relations - Atara Biotherapeutics | investors.atarabio.com Reviews
<META>
DESCRIPTION
The Investor Relations website contains information about Atara Biotherapeutics business for stockholders, potential investors, and financial analysts.
<META>
KEYWORDS
1 pipeline
2 clinical trials
3 investors
4 careers
5 nbsp;
6 atara bio
7 investor relations
8 press releases
9 events and presentations
10 corporate governance
CONTENT
Page content here
KEYWORDS ON
PAGE
pipeline,clinical trials,investors,careers,nbsp;,atara bio,investor relations,press releases,events and presentations,corporate governance,financials and filings,stock information,investor faqs,intra,shareholder tools,briefcase,printed materials,downloads
SERVER
Microsoft-IIS/6.0
POWERED BY
ASP.NET
CONTENT-TYPE
utf-8
GOOGLE PREVIEW

Investor Relations - Atara Biotherapeutics | investors.atarabio.com Reviews

https://investors.atarabio.com

The Investor Relations website contains information about Atara Biotherapeutics business for stockholders, potential investors, and financial analysts.

INTERNAL PAGES

investors.atarabio.com investors.atarabio.com
1

Printed Materials - Atara Biotherapeutics

http://investors.atarabio.com/printed-materials.cfm

No documents are currently available to order by mail.

2

2015 Canaccord Genuity Growth Conference - Atara Biotherapeutics

http://investors.atarabio.com/eventdetail.cfm?EventID=163858

2015 Canaccord Genuity Growth Conference. August 12, 2015.

3

Investor Relations - Atara Biotherapeutics

http://investors.atarabio.com/index.cfm

November 3, 2016. Atara Bio's Collaborating Investigators to Present Results from Phase 2 Trial of Allogeneic Cytomegalovirus (CMV)-specific Cytotoxic T Lymphocytes (CTL) at the American Society of Hematology (ASH) Annual Meeting 2016. October 18, 2016. Atara Bio Granted Access to Priority Medicines (PRIME) Regulatory Support for Allogeneic Epstein-Barr Virus (EBV)-Specific Cytotoxic T Lymphocytes (CTL) for Treatment of EBV-Associated Post Transplant Lymphoproliferative Disorder (EBV-PTLD).

4

Events & Presentations - Atara Biotherapeutics

http://investors.atarabio.com/events.cfm

Details on upcoming events are not yet available. Please click here. To be notified of all upcoming events. September 12, 2016. Morgan Stanley Global Healthcare Conference. August 10, 2016. Canaccord Genuity 36th Annual Growth Conference. June 21, 2016. JMP Securities 2016 Life Sciences Conference. Location: The St. Regis New York Hotel, New York, NY. June 6, 2016. 5:18 PM CT to 5:30 PM CT. Oral Presentation: Treatment of EBV Nasopharyngeal Carcinoma with Banked EBV-Specific Cytotoxic T Cells. Atara Bio ...

5

Press Releases - Atara Biotherapeutics

http://investors.atarabio.com/releases.cfm

August 8, 2016. Atara Bio Announces Second Quarter 2016 Financial Results and Recent Highlights. SOUTH SAN FRANCISCO, Calif., Aug. 08, 2016 (GLOBE NEWSWIRE) - Atara Biotherapeutics, Inc. (Nasdaq:ATRA), a biopharmaceutical company focused on developing meaningful therapies for patients with severe and life-threatening diseases, today reported financial results for the second quarter ended June 30, 2016 and recent operational . File is in Briefcase. August 4, 2016. File is in Briefcase. July 12, 2016.

UPGRADE TO PREMIUM TO VIEW 11 MORE

TOTAL PAGES IN THIS WEBSITE

16

LINKS TO THIS WEBSITE

atarabio.com atarabio.com

Careers – Atara Biotherapeutics

http://www.atarabio.com/careers

atarabio.com atarabio.com

T-Cell Product Candidates – Atara Biotherapeutics

http://www.atarabio.com/pipeline/t-cell-product-candidates

We acquired exclusive worldwide rights to three clinical stage, off-the-shelf T-cell product candidates from Memorial Sloan Kettering Cancer Center (MSK). Activated T-cells are designed to harness the power of the immune system to recognize and attack cancer cells and cells infected with certain viruses. T-cells may be effective even after failure of multiple other agents, and may avoid the toxicities of current treatments in patients with cancers and serious viral infections. EBV-CTLs.

atarabio.com atarabio.com

Pipeline – Atara Biotherapeutics

http://www.atarabio.com/pipeline

atarabio.com atarabio.com

Molecularly-Targeted Product Candidates – Atara Biotherapeutics

http://www.atarabio.com/pipeline/molecularly-targeted-product-candidates

We are developing biologics that target myostatin and activin, growth factors which are members of the Transforming Growth Factor-Beta, or TGF-β, protein superfamily. Myostatin and activin play roles in the growth and maintenance of muscle and many other body tissues. STM 434. Is a ligand trap that targets Activin A (and other related factors) and is being studied in a Phase 1 clinical study in patients with ovarian cancer and other solid tumors.

atarabio.com atarabio.com

Company – Atara Biotherapeutics

http://www.atarabio.com/company

atarabio.com atarabio.com

Clinical Trials – Atara Biotherapeutics

http://www.atarabio.com/clinical-trials

Therapeutic Effects of Epstein-Barr Virus Immune T-Lymphocytes Derived From A Normal HLA- Compatible Or Partially- Matched Third-Party Donor in the Treatment of EBV Lymphoproliferative Disorders and EBV-Associated Malignancies. Biological Therapy in Treating Patients at High-Risk or With Lymphoma, Lymphoproliferative Disease, or Malignancies. Dose Escalation Trial of WT1-Sensitized T Cells for Residual or Relapsed Leukemia After Allogeneic Hematopoietic Progenitor Cell Transplantation.

UPGRADE TO PREMIUM TO VIEW 2 MORE

TOTAL LINKS TO THIS WEBSITE

8

SOCIAL ENGAGEMENT



OTHER SITES

investors.asn.au investors.asn.au

Investor Education Seminars Self Managed Super Fund Information - Australian Investors' Association » Australian Investors Association

Australia’s leading non-profit organisation providing assistance to its members to make improved investment decisions. A smorgasbord of ideas, education and strategies to consider as you make financial decisions to suit your own goals, skills, resources and risk profile. Opportunities to network with other members, many with considerable experience and success in investing. Our motto: Investors helping investors . NON MEMBERS - Sign up for our free "Investor Update" newsletter. And tell us whether you ag...

investors.aspireuniversal.com investors.aspireuniversal.com

Aspire Investor Microsites | Log In

Thank you. We have sent a password to the email address specified. Please use this password to log in. A password has been created and sent to the specified email. The old password has been discontinued and will no longer allow access to this site. Please enter a valid email address below. We're sorry, but we couldn't find that email address on our list. We're sorry, but something went wrong. Please reload the page, and try again. Thank you. The email/password combination you entered is incorrect.

investors.assetz.co.uk investors.assetz.co.uk

Investment property - buy to let property - investment properties - investment property for sale UK - buy to let estate agent

Search our Buy-to-let Properties. View All - Types. View All - Regions. Yorkshire and the Humber. Quick Register Why should I register? The Buy to Let Estate Agent. Assetz for Investors locates and pre-negotiates carefully selected investment-grade buy-to-let property. For private investors who wish to develop an investment business or portfolio. We offer a range of investment opportunities including new-build. And freehold property, along with a range of finance. The UK's Top Developments. I was really ...

investors.astronovainc.com investors.astronovainc.com

AstroNova, Inc. - Investors - Investors

Is now Astro Nova. AstroNova Test and Measurement. Annual Reports and Proxy. Board Committees and Charters. Email Alerts and RSS. About span class=no-mobile Us /span. Span class=no-mobile Our /span Culture. Span class=no-mobile Our /span Businesses. Annual Reports and Proxy. Board Committees and Charters. Email Alerts and RSS. Span class=mobile Search /span span class=no-mobile img src=/files/design/icon search.png /span. Contact span class=no-mobile Us /span. About span class=no-mobile Us /span. AstroNo...

investors.atalian.com investors.atalian.com

Investors AreaHomepage - Investors Area

Our business is multi-business. Pursuing its aim to always better support its customers, ATALIAN allied with the leading companies of the European Facilities Services market Read more. Each day ATALIAN implements dynamic economic growth combined with dynamic social progress and a responsible commitment to preserve the environment. Read more. Service gagnant N 11. Welcome to investors area.

investors.atarabio.com investors.atarabio.com

Investor Relations - Atara Biotherapeutics

Our mission is to develop novel treatment options for patients with severe and life-threatening conditions that have been underserved by scientific innovation. We are investigating therapies targeting unique pathways to pause or reverse patients’ underlying diseases. August 6, 2015. Atara Biotherapeutics Announces Second Quarter 2015 Results. July 15, 2015. Atara Bio Announces Closing of Underwritten Offering of Common Stock and Full Exercise of Underwriters' Option to Purchase Additional Shares.

investors.atento.com investors.atento.com

Atento - Investor Relations - Company Overview

Atento: Great Place To Work. Join the Atento team. Stock Quote, Historical, Chart, Calculator. Atento in the World. USA and Puerto Rico. Together we can do anything. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Stock Quote, Historical, Chart, Calculator. 98 delivery centers in 14 countries. 160,000 employees and 89,000 workstations. Long-standing relationships with 400 blue-chip clients. Strong relationship with Telefónica, supported by a Master Services Agreement ( MSA ) through 2021. We hav...

investors.atlanticpower.com investors.atlanticpower.com

Corporate Profile | Atlantic Power Corporation

Email Notification for TSX. Email Notification for NYSE. Supplementary Investor Materials - September 16, 2014. 2015 Annual General and Special Meeting. Atlantic Power Corporation Second Quarter 2015 Conference Call. Tuesday, August 11, 2015, 8:30 am ET. Atlantic Power Corporation ATP Conference Call. Friday, May 8, 2015, 8:30 am ET. Atlantic Power Corporation Fourth Quarter 2014 Conference Call. Friday, February 27, 2015, 8:30 am ET. Atlantic Power Corporation Third Quarter 2014 Conference Call. Atlanti...

investors.atlanticus.com investors.atlanticus.com

Atlanticus - For Investors - Corporate Profile

Annual Meeting of Shareholders. News and Market Information. Forward-Looking Information and Risk Factors. Â Â Corporate Information. Â Â Corporate ProfileÂ. Invests in businesses primarily focused in the financial services industry. The company exists to create value â for our customers, our employees and our shareholders. List of all companies in The SNL U.S. Finance Company Index. As of August 14, 2015. Minimum 20 minute delay. Atlanta, GA 30328. 770) 828-2000 investors@atlanticus.com. Â Â Terms of Use.

investors.atlassian.com investors.atlassian.com

Atlassian - Investors Overview

Project and issue tracking. IT and business service desk. Team chat, video, file sharing. Plan, build, and ship amazing products. Provide great service and support your business. Bring together a winning go-to-market strategy. Simplify what it takes to report, measure, and analyze. Run your business smoothly and efficiently. Streamline processes for better people management. Securely and reliably manage clients and documents. Work smart and deliver fast with any team. Guides to all our products. Atlassia...

investors.atlasventure.com investors.atlasventure.com

Login

If you have forgotten your Username or Password, please click here. For assistance logging into WebLP, please email Atlas Venture LP Relations at: lprelations@atlasventure.com. 2000-10 AnalytX, Inc.